Home|Attorneys|Brendan P. Glackin

Brendan P. Glackin
Partner, San Francisco Office
email
415 956-1000
vcard

Brendan P. Glackin

Brendan P. Glackin chairs the firm’s antitrust practice group and supports the firm’s antitrust cases. He has practiced antitrust law for nearly two decades  and has tried more than 20 civil and criminal cases. His successes include the titanium dioxide antitrust class action ($163.5 million in settlements); the liquid crystal displays (LCDs) price-fixing litigation ($470 million in settlements); and the Norvir antitrust litigation. Mr. Glackin served as trial counsel in all three cases and, via LCDs, remains one of small number of plaintiff attorneys in America to have successfully taken a class action antitrust case to verdict before a jury. His work against price-fixing cartels has continued in his representation of a class of indirect purchasers in the Lithium Ion Batteries price-fixing litigation. Mr. Glackin also has contributed groundbreaking work in litigation against drug makers for blocking access to affordable generics including the blockbuster brand-name prescription drug Cipro ($399 million in settlements), which led to a 2016 “California Lawyer Attorney of the Year” (CLAY) award.  He also serves as lead counsel for Nashville General Hospital and District Council 37 in a class-action antitrust case against Sandoz and Momenta Pharmaceuticals for monopolizing enoxaparin, the generic version of the blockbuster anti-coagulant Lovenox.

Mr. Glackin also shared with others at the firm a well-deserved 2019 “Outstanding Antitrust Litigation Achievement in Private Law Practice” award from the American Antitrust Institute for his work on Seaman v. Duke, a class action case around wage suppression, challenging a secret no-hire agreement between the Duke and UNC Medical School Deans which led to a final settlement of $54.5 million in 2019. Cipro Cases I and II, JCCP Nos. 4154 and 4220 (Cal. Supr. Ct.); Seaman v. Duke University, No. 1:15-cv-00462 (M.D. N.C.).

Mr. Glackin presently serves as lead counsel in a proposed class action against the one of the largest healthcare systems in America, Atrium Health, the dominant healthcare provider in North Carolina. The case follows on a civil enforcement action brought by the Department of Justice and the North Carolina Attorney General, which alleged harm to competition caused by anti-competitive terms in Atrium Health’s contracts with insurers. Mr. Glackin and Lieff Cabraser remain the only attorneys willing to represent hundreds of thousands of North Carolinians victimized by this conduct.

In 2019 and 2020, Mr. Glackin was named one of Lawdragon’s 500 Leading Lawyers in America and The Daily Journal named him a Top Antitrust Lawyer in California in 2020. He has also been listed as a “Super Lawyer for Northern California” from 2013 to 2020.

Mr. Glackin’s many contributions to the bar and the practice of law include the following. He has regularly been tapped to teach trial advocacy and negotiation skills by the Practising Law Institute (PLI); he is also annually invited to teach trial advocacy with the National Institute for Trial Advocacy (NITA). He serves as a Vice-Chair of the American Bar Association Section of Antitrust Law, Global Private Litigation Committee, and was a founding member of the Executive Committee of the Antitrust Section of the Bar Association of San Francisco. He has been a past panelist at the ABA Antitrust Section Spring Meeting, the pre-eminent gathering of antitrust lawyers in the world. He routinely speaks, publishes, and teaches on antitrust issues.

Long form bio (click to open pdf).

  • Harvard Law School, Cambridge, Massachusetts
    J.D. (Cum Laude) – 1998
  • University of Chicago, Chicago, Illinois
    A.B. – 1995
  • California, 1998
  • New York, 2000
  • U.S. Court of Appeals, 2nd Circuit, 2013
  • U.S. Court of Appeals, 4th Circuit, 2016
  • U.S. Court of Appeals, 9th Circuit, 2004
  • U.S. District Court, Central District of California, 2001
  • U.S. District Court, Eastern District of California, 2001
  • U.S. District Court, Northern District of California, 2001
  • U.S. District Court, Southern District of California, 2001
  • U.S. District Court, Southern District of New York, 2001
  • American Bar Association, Vice-Chair, Global Private Litigation Committee (2020)
  • Bar Association of San Francisco Antitrust Section, Executive Committee
  • State Bar of California
  • Moderator, “Collective Actions in Europe: An Update,” ABA Antitrust Law Section, 2021
  • “The Antitrust of Dominant Hospital Systems: United States v. CMHA and UFCW v. Sutter Health,” ABA Antitrust Law Section, 2020
  • Antitrust and Silicon Valley: New Themes and Direction in Competition Law and Policy, Santa Clara University School of Law, 2019
  • Antitrust Trials: The View From the Trenches, 2013
  • Applying Settlements Offsets to Antiftust Judgments, ABA Spring Meetings, 2013
  • California Trial Advocacy, PLI, 2013
  • Building Trial Skills, NITA, 2013
  • Antitrust Institute: Developments & Hot Topics, 2011
  • Ramifications of American Needle, Inc. v. National Football League
  • Selected for inclusion by peers in The Best Lawyers in America in field of “Litigation – Antitrust,” 2021, 2022
  • “Titan of the Plaintiffs Bar,” Law360, 2021
  • “Lawdragon 500 Leading Plaintiff Financial Lawyers in America,” Lawdragon, 2019-2021
  • “Super Lawyer for Northern California,” Super Lawyers, 2013-2021
  • “Outstanding Private Practice Antitrust Achievement,” American Antitrust Institute, 2020
  • “Top Antitrust Lawyers in California,” Daily Journal, 2020
  • “Outstanding Private Practice Antitrust Achievement,” American Antitrust Institute, 2019
  • “California Lawyer Attorney of the Year (CLAY) Award,” California Lawyer, 2016